A clinical pathway for postoperative management and early patient discharge: does it work in gynecologic oncology? - 21/08/11
Résumé |
Objective |
This study evaluates a postoperative clinical pathway among gynecologic oncology patients.
Study Design |
880 surgical admissions were retrospectively reviewed at an institution which used a clinical pathway consisting of early feeding and ambulation as well as prompt discontinuation of intravenous fluids with conversion to oral analgesics. Readmission, mortality, and complication rates were calculated. Patient proportions were compared by using the χ2, Mann-Whitney, and t tests.
Results |
40% of the surgeries were radical and/or staging procedures and 100% underwent open laparotomies. The median length of hospital stay was 2 days. Only 5% required readmission. The median time to readmission was 4 days. Those patients with a longer initial length of hospital stay and higher mean blood loss were more likely to be readmitted (P < .01). The most common diagnosis was endometrial carcinoma (n = 188). This subgroup also had a median length of hospital stay of 2 days and the readmission rate was 3.6%. The perioperative mortality rate was low in the group as a whole with only 1 death (0.2%). There were no reoperations for hemoperitoneum or urinary or intestinal fistulas.
Conclusion |
This management approach resulted in a length of hospital stay of 2 days without increasing morbidity or mortality after laparotomy for suspected gynecologic malignancy.
Le texte complet de cet article est disponible en PDF.Key words : clinical pathway, gynecologic oncology, postoperative care
Plan
| Reprints not available from the authors. |
|
| Cite this article as: Chase DM, Lopez S, Nguyen CN, et al. A clinical pathway for postoperative management and early patient discharge, does it work in gynecologic oncology? Am J Obstet Gynecol 2008;199:541.e1-541.e7. |
Vol 199 - N° 5
P. null - novembre 2008 Retour au numéro
Article précédent
- Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studies
- Steven C. Plaxe, Sandra E. Brooks, Chunquiao Tian, Jeffrey D. Bloss, David H. Moore, Harry J. Long
- GATA3 expression in estrogen receptor ⍺-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival
- Ingeborg B. Engelsen, Ingunn M. Stefansson, Lars A. Akslen, Helga B. Salvesen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?